101 – 110 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients
- Contribution to journal › Article
-
Mark
High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23 796 consecutive autopsies
- Contribution to journal › Letter
-
Mark
Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A
- Contribution to journal › Article
-
Mark
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
- Contribution to journal › Article
- 2006
-
Mark
Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.
- Contribution to journal › Article
-
Mark
Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects
- Contribution to journal › Letter
-
Mark
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study
- Contribution to journal › Article
-
Mark
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis
- Contribution to journal › Article
-
Mark
Are randomized clinical trials the only truth? Not always
- Contribution to journal › Debate/Note/Editorial
-
Mark
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
- Contribution to journal › Scientific review
